Get startedLog in
    Picture of Seres Therapeutics logo

    MCRB — Seres Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    All News

    Brief: Seres Therapeutics, Nestlé Health Science Announce U.S. Commercial Availability Of VOWST

    Picture of Seres Therapeutics logoSeres Therapeutics
    05/06/2023 12:51
    June 5 (Reuters) - Seres Therapeutics Inc  MCRB.O :
    * SERES THERAPEUTICS AND NESTLÉ HEALTH SCIENCE ANNOUNCE U.S.
COMMERCIAL AVAILABILITY OF VOWST, THE FIRST AND ONLY
FDA-APPROVED MICROBIOTA-BASED ORAL THERAPEUTIC FOR PREVENTION OF
RECURRENCE OF C. DIFFICILE INFECTION
    * SERES THERAPEUTICS INC - VOWST IS NOW AVAILABLE BY
PRESCRIPTION
IN U.S. FOR ADULT PATIENTS FOLLOWING ANTIBIOTIC TREATMENT FOR
RECURRENT CDI

Source text for Eikon:  ID:nBw928x0fa 
Further company coverage:  MCRB.O 

 ((Reuters.Briefs@thomsonreuters.com))

    Recent news on Seres Therapeutics

    See all news